Sign in
4

Changes in Ownership

Krystal Biotech, Inc. Filed Acc 0001209191-20-030562

President and CEO sold 50,000 shares at an average $58.14 ($2,906,907)

From the SEC's structured data for this filing

Trades in this filing

Krishnan Krish S · President and CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-15 Sale : show line 1 in the form −3,842 $57.43 $220,639 1,932,620 D
2020-05-15 Sale : show line 2 in the form −12,445 $58.09 $722,873 1,920,175 D
2020-05-15 Sale : show line 3 in the form −10,552 $59.03 $622,874 1,909,623 D
2020-05-18 Sale : show line 4 in the form −2,900 $55.99 $162,357 1,906,723 D
2020-05-18 Sale : show line 5 in the form −6,784 $56.84 $385,589 1,899,939 D
2020-05-18 Sale : show line 6 in the form −5,371 $57.63 $309,532 1,894,568 D
2020-05-18 Sale : show line 7 in the form −1,805 $59.11 $106,699 1,892,763 D
2020-05-18 Sale : show line 8 in the form −6,301 $59.73 $376,345 1,886,462 D
Open-market sales · 50,000 sh · avg $58.14 · $2,906,907
Loading xslF345X03/doc4.xml…